Halozyme Therapeutics, Inc. (HALO)

71.71 +1.28 (+1.82%) USD  |  NASDAQ  |  Jan 21, 16:00
71.71 0.00 (0.00%) After-Hours: 20:00
More

Halozyme Therapeutics Stock Based Compensation (Per Share Quarterly)

Stock Based Compensation (Per Share Quarterly) Chart

View Stock Based Compensation (Per Share Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years

View Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Per Share Quarterly) Benchmarks

View Stock Based Compensation (Per Share Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. Upgrade